G. W. Canonica, C. E Baena-Cagnani., J. Bousquet, P. J. Bousquet, R. F. Lockey, H. T. Mailing, et al., “Recommendations for Standardizations for Clinical Trials with Allergen Specific Immunotherapy for Respiratory Allergy. A Statement of WHO Task Force,” Allergy, Vol. 62, No. 3, 2007, pp. 317-324.

has been cited by the following article:

• TITLE: Clinical Efficacy of Allergen Specific Immunotherapy (ASIT) in Allergic Rhinitis

  AUTHORS: Rao Sukhesh

  KEYWORDS: Allergen Specific Immunotherapy, Allergic Rhinitis

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.2 No.4, September 30, 2011

  ABSTRACT: Though efficacy of Allergen Specific Immunotherapy (ASIT) has been proved in many studies, reports about success in clinical practice and under field conditions in alleviating the suffering or decreasing the morbidity in patients of Allergic Rhinitis are few. 260 patients of Allergic Rhinitis without coexisting diseases were included. Skin prick test was done on all patients. ASIT was initiated with common inhalant indoor allergens as per standard protocol and patients were assessed at the start and at 2 m, 6 m and 18 months of ASIT. ASIT was able to significantly reduce the symptom score in all the three groups namely sneezing, rhinorrhoea and nasal itching (p